Skip to main content
OpenTrials
Completed

NCT Number: NCT05970939

Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ

Neurological diseases are central nervous system diseases that cause an increase in the level of disability and limitations in daily life. Multiple Sclerosis (MS), stroke, and Parkinson's Disease (PD) are among the most common apparent neurological diseases, and epidemiological studies show that their prevalence has increased over time worldwide. Although MS, stroke, and PD have different causes and neurological aspects, they generally cause motor, sensory, and/or cognitive impairments, leading to restriction of the individual's activities and participation. Today, physiotherapy and rehabilitation approaches together with optimal medical and surgical treatment are the cornerstones of treatment for these diseases. Recently, it has been stated that various telerehabilitation interventions in the field of physiotherapy and rehabilitation may be an additional option to the rehabilitation approaches applied in the clinic. On the other hand, It is important to evaluate the level of usability in expanding the usability of telerehabilitation services and determining the best telerehabilitation service. For this reason, there is a need for questionnaires investigating the satisfaction level of physiotherapy and rehabilitation applied through telerehabilitation.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Questionnaire items will be created in two stages. First, 5 experts will independently review the literature on "telerehabilitation" and "usability". In addition, these experts will be asked to create a pool of questions based on their experiences in telerehabilitation and by taking the opinions of patients receiving telerehabilitation about usability. Then, 5 experts will come together and obtain a single question pool containing the questions they deem important in their question pool. The second step will involve scaling the elements. In this study, scale items will be scored on a five-point Likert scale, ranging from 1, strongly disagree to 5, strongly agree. Then, it will be applied to a pilot group of 10 people and it will be evaluated whether the items prepared by the experts are understood by the patients. In line with the expert opinion and the result of the pilot study, the final version of the scale will be decided and applied to MS, PD, and stroke patients who make up the study group. Finally, the validity and reliability of the questionnaire will be calculated.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Voluntarily participate in research to accept
  • Mini-Mental Test score more than or equal 24
  • Previously receiving physical therapy through telerehabilitation

Exclusion criteria

  • Any visual, hearing, and perception problems that may affect the answering the questionnaire items

Treatment and study plan

Development of the Telerehabilitation Usability Questionnaire

Other

This study will be examined the development, validity, and reliability of the Telerehabilitation Usability Questionnaire in patients with MS.

Primary outcomes

  1. Telerehabilitation Usability Questionnaire in patients with Neurological disease

    Time frame: Baseline

    Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale

  2. Telerehabilitation Usability Questionnaire in patients with Neurological disease-Second

    Time frame: he second assessment will be conducted after the one week

    Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ in Neurological Diseases

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 2, 2023
Registry last updated
Nov 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.